Bas J. Wouters

发表

Text-derived concept profiles support assessment of DNA microarray data for acute myeloid leukemia and for androgen receptor stimulation

Barend Mons, Rob Jelier, Jan A. Kors, 2007, BMC Bioinformatics.

HAT: Hypergeometric Analysis of Tiling-arrays with application to promoter-GeneChip data

Marcel J. T. Reinders, Erdogan Taskesen, Jeroen de Ridder, 2010, BMC Bioinformatics.

Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity.

Erdogan Taskesen, Bob Löwenberg, Bas J. Wouters, 2011, Blood.

Brief Report Results and Discussion

Bas J. Wouters, W. van Putten, B. Löwenberg, 2022 .

Risk stratification of intermediate-risk acute myeloid leukemia: integrative analysis of a multitude of gene mutation and gene expression markers.

Veronika Rockova, Bob Löwenberg, Bas J. Wouters, 2011, Blood.

C/EBPγ deregulation results in differentiation arrest in acute myeloid leukemia.

Bas J. Wouters, D. Tenen, A. Melnick, 2012, The Journal of clinical investigation.

Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling

Bas J. Wouters, R. Verhaak, B. Löwenberg, 2009, Haematologica.

Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia.

Bas J. Wouters, B. Wouters, R. Delwel, 2016, Blood.

ADVANCES IN ACUTE MYELOID LEUKEMIA Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia

Bas J. Wouters, B. Wouters, R. Delwel, 2015 .

Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic Modifiers.

Francine E. Garrett-Bakelman, Bas J. Wouters, O. Elemento, 2017, Cancer discovery.

Genomic and Epigenomic Studies of Acute Myeloid Leukemia with CEBPA Abnormalities

Bas J. Wouters, B. Wouters, 2009 .

A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects.

Bas J. Wouters, B. Löwenberg, R. Delwel, 2009, Blood.

leukemia: flashback and prospects A decade of genome-wide gene expression profiling in acute myeloid

Bas J. Wouters, B. Wouters, R. Delwel, 2010 .

C/EBPa mutations in lung cancer

Bas J. Wouters, M. Meyerson, D. Tenen, 2006 .

A Transcriptional Profiling Study of CCAAT/Enhancer Binding Protein Targets Identifies Hepatocyte Nuclear Factor 3β as a Novel Tumor Suppressor in Lung Cancer

Bas J. Wouters, T. Golub, S. Monti, 2004, Cancer Research.

C/EBP alpha mutations in lung cancer.

Bas J. Wouters, M. Meyerson, D. Tenen, 2006, Lung cancer.

Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1.

Pu Zhang, Bob Löwenberg, Bas J. Wouters, 2007, Blood.

Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations.

Bas J. Wouters, Sangmin Lee, G. Roboz, 2017, The Journal of molecular diagnostics : JMD.

with silenced CEBPA and mutations in NOTCH1 Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia

Bas J. Wouters, R. Verhaak, Y. Yashiro‐Ohtani, 2013 .

Segmental uniparental disomy as a recurrent mechanism for homozygous CEBPA mutations in acute myeloid leukemia

Bas J. Wouters, M. Sanders, B. Löwenberg, 2007, Leukemia.

Genome-wide epigenetic analysis delineates a biologically distinct immature acute leukemia with myeloid/T-lymphoid features.

Lucy Skrabanek, Bob Löwenberg, Bas J. Wouters, 2009, Blood.

A recurrent in-frame insertion in a CEBPA transactivation domain is a polymorphism rather than a mutation that does not affect gene expression profiling-based clustering of AML.

Bas J. Wouters, B. Löwenberg, B. Wouters, 2007, Blood.

Tribbles homolog 2 inactivates C/EBPalpha and causes acute myelogenous leukemia.

Bas J. Wouters, J. Aster, Carlos G. Rodriguez, 2006, Cancer cell.

Corrigendum ( January 2013 ) C / EBP g deregulation results in differentiation arrest in acute myeloid leukemia

Bas J. Wouters, D. Tenen, A. Melnick, 2018 .

Allele-specific expression of GATA2 due to epigenetic dysregulation in CEBPA double mutant AML.

Bas J. Wouters, A. Melnick, M. Rehli, 2021, Blood.

Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation.

Bas J. Wouters, M. Minden, O. Abdel-Wahab, 2019, Cancer cell.

Response: CEBPA promoter hypermethylation in a subset of myeloid/T-lymphoid leukemias with a distinct gene expression profile

Bas J. Wouters, B. Wouters, R. Delwel, 2009 .

Hitting the target in IDH2 mutant AML.

Bas J. Wouters, 2017, Blood.

Series ADVANCES IN ACUTE MYELOID LEUKEMIA Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia

Bas J. Wouters, B. Wouters, R. Delwel, 2015 .

Targeting IDH1 and IDH2 Mutations in Acute Myeloid Leukemia: Emerging Options and Pending Questions

Bas J. Wouters, B. Wouters, 2021, HemaSphere.

Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid/lymphoid leukemia

Juan M. Vaquerizas, Bas J. Wouters, Dagmar Glatz, 2024, Nature communications.

BCL6 maintains survival and self-renewal of primary human acute myeloid leukemia cells.

Bas J. Wouters, C. Mason, A. Melnick, 2020, Blood.

as a Novel Tumor Suppressor in Lung Cancer β Factor 3 Binding Protein Targets Identifies Hepatocyte Nuclear A Transcriptional Profiling Study of CCAAT / Enhancer

Bas J. Wouters, T. Golub, S. Monti, 2004 .

Gene expression profiling for improved dissection of acute leukemia: a recently identified immature myeloid/T-lymphoid subgroup as an example.

Bas J. Wouters, B. Wouters, R. Delwel, 2008, Blood Cells, Molecules & Diseases.